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Available online 9 June 2017AbstractPurpose: To determine the prevalence of color vision deficiency (CVD) in the northeast of Iran.
Methods: This cross-sectional, population-based study was conducted in Mashhad, in the northeast of Iran. Multistage cluster sampling was used
for selecting the participants. After preliminary screening, the subjects underwent a complete ophthalmic examination. The examination
included the measurement of visual acuity, refraction, and slit-lamp biomicroscopy. The Farnsworth D-15 test was used to detect CVD. The color
vision test was done with the best optical correction.
Results: Of the 4453 invitees, 3132 participated in the study (response rate: 70.4%). The overall prevalence of CVD in this study was 13.93%
[95% confidence interval (CI): 12.44e15.41]. The prevalence of CVD in males and females was 15.85% (95% CI: 13.26e18.44) and 12.96%
(95% CI: 11.22e14.71), respectively. The most prevalent types of CVD were tritanopia (6.96%; 95% CI: 5.84e8.08), deuteranopia (3.92%; 95%
CI: 3.14e4.70) and tritanomalous (2.21%; 95% CI: 1.55e2.86), respectively. According to the results of logistic regression, the odds of having
protanopia were higher in females than males [Odds ratio (OR) ¼ 4.80; 95% CI: 1.20e19.18]. The odds of having deuteranopia were lower in
females than males (OR ¼ 0.52; 95% CI: 0.35e0.76). The odds of having CVD were lower in 16e30 (OR ¼ 0.52; 95% CI: 0.37e0.73) and
higher in 46e60 (OR: 1.41; 95% CI: 1.01e1.97) year age groups compared to 7e15 year age group. The odds of having tritanopia in 16e30 and
46e60 year age groups was 0.56 (95% CI: 0.35e0.90) and 1.79 (95% CI: 1.19e2.67) compared to 7e15 year age groups, respectively.
Conclusion: The prevalence of CVD was high in this study, especially in males and people over 46 years of age. Planning for involvement of
ocular disease control programs in health care systems can be helpful in the reduction of CVD and improving the quality of life in affected
patients.
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Color vision deficiency (CVD) is one of the most important
visual disorders affecting a considerable percentage of the
population.1 CVD may be congenital or acquired.2,3 Congen-
ital forms of CVD occur as a result of dysfunction in the cone
cells, and the patient experiences different problems inosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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of the involved photoreceptor. Color blindness is classified
into two main groups of red-green deficiency and blue-yellow
deficiency according to the defective cone cells. Red-green
deficiency in the most common type.4,5 The acquired type of
CVD has various subtypes caused by different diseases. The
type of the defect depends on what part of the visual system,
including the retina, optic nerve, and visual cortex, is affected
by the disease or injury.6,7
The prevalence of congenital color blindness is different in
various parts of the world. For example, 8% of men and 0.4%
of women are color blind in western countries.8 The preva-
lence of CVD is 4e6.5% in Japan and China,2,3 4% in African
countries,9 7.3% in Turkey,4 and 2.9e11% in Saudi
Arabia.10,11 However, the prevalence of acquired color
blindness varies according to occupation, sex, and age, and has
been reported to be 5e20% in different studies.1,12e15
Although no treatment has been found for this reason, some
color lenses and gene therapy are available for the patients, but
the results are not always satisfactory. For this reason, color
blind people usually experience disorders in daily activities,
learning, and skill acquisition for certain professions and
therefore cannot have certain jobs.16 As a result, they have a
decreased quality of life and experience socioeconomic
problems.17
Few studies have addressed the prevalence of CVD in Iran,
and the available studies have covered different areas with
different results. A study in Shahroud1 reported a prevalence
of 4.4% and 10.1% for congenital and acquired CVD, and
other studies in Tehran,18 the schools of Zanjan,19 and the
general population of Qazvin20 reported a prevalence of 8.8%,
8.07%, and 3.49% for CVD, respectively, indicating differ-
ences in the prevalence of this disease in different parts of the
country. Considering the importance of CVD, there is a need
for comprehensive information on its status to make effective
plans for it. Population-based studies can meet this need and
provide health policy makers with a better perspective of this
disease. Therefore, we conducted this study to evaluate the
prevalence of CVD in Mashhad, the second largest city in Iran.
Methods
This cross-sectional, population-based study was con-
ducted in the urban population of Mashhad. The target
population of the study was all residents of Mashhad aged
above 1 year. The population of Mashhad was 2,451,712
according to a 2005 population census. Stratified cluster
sampling was used to select the participants proportional to
the population of different districts of Mashhad (municipality
districts were considered as strata). A number of clusters
were selected in each district proportional to the number of
households. In total, 120 clusters were randomly selected
from blocks determined by Statistics Center of Khorasan
Razavi, and the first house number in each cluster was
considered as the cluster head. In each cluster, sampling was
systematically continued for up to 10 households. First,
the interviewers introduced themselves, explained theimportance of this project for the household, and completed a
demographic questionnaire. Then they were invited to attend
the Optometry Clinic of Mashhad University of Medical
Sciences for complete ophthalmic examination. Sampling
was systematically continued in a clockwise manner for up
to 10 households. If a household was not willing to partici-
pate or was not present in the house, the next house number
was invited. All participants were transported to the Clinic
by the research team.
The Ethics Committee of Mashhad University of Medical
Sciences approved the study protocol, which was conducted in
accord with the tenets of the Declaration of Helsinki. All
participants signed a written informed consent.
First, the uncorrected visual acuity was measured with an E
Snellen chart. Then objective refraction was performed using
an auto refractometer (TOPCON, KR-8000, Japan), and the
results of auto refraction were refined with retinoscopy
(HEINE BETA). In the next step, the best far and near optical
correction was determined using subjective refraction, and
near and distance best corrected visual acuity were recorded.
The Farnsworth D-15 test was used to assess color vision in
all individuals aged over 7 years in similar light conditions
with optical correction (near optical correction was used in
presbyopic participants). The participants had only 5 min to
finish the test. However, those aged above 50 years were given
a little more time due to their increased reaction time.
Participants younger than 6 years of age, participants with a
previous history of intraocular surgeries, and those who did
not complete the color vision test were excluded from the
study.Statistical analysisIn this study, the prevalence of CVD is reported as per-
centage along with 95% confidence interval (CI). In calcu-
lating CIs, we used binomial distribution when the distribution
was not normal. The design effect was considered for the
calculation of standard error. The effect of cluster sampling
was regarded when calculating the CI. Simple and multiple
logistic regressions were used to evaluate the relationship of
CVD and its types with age and sex. A p-value of less than
0.05 was considered statistically significant.
Results
Of the 4453 invitees, 3132 subjects participated in the study
(response rate: 70.4%). After applying the exclusion criteria,
eventually there were 2628 subjects available for this analysis.
The mean age of the participants was 31.54 ± 16.9 years
(range, 7e90 years), and 1751 of them (66.6%) were female.
The prevalence of CVDwas 13.93% (95%CI: 12.44e15.41)
in the study population, 15.85% (95%CI: 13.26e18.44) inmen,
and 12.96% (95% CI: 11.22e14.71) in women. Tritanopia was
the most common type of CVD with a prevalence of 6.96%
(95% CI: 5.84e8.08), followed by deuteranopia, and trita-
nomalous with a prevalence of 3.92% (95%CI: 3.14e4.70), and
2.21% (95% CI: 1.55e2.86), respectively.
82 H. Hashemi et al. / Journal of Current Ophthalmology 31 (2019) 80e85According to the results of this study, the highest preva-
lence of CVD was observed in the age groups: over 60 years
(20.93%; 95% CI: 13.63e28.23), 46e60 years (20.53%; 95%
CI: 16.31e24.75), and 7e15 years (15.64%; 95% CI:
12.84e18.43), respectively. Regarding the type of CVD, tri-
tanopia was the most prevalent type in all age groups. The
prevalence of other types of CVD has been shown in Table 1.
Table 2 shows the results of simple and multiple logistic
regressions for CVD and its types with respect to the age and
sex. We considered the results of multiple model for inter-
pretation of the data. According to this, the odds of protanopia
in females were 4.80 (95% CI: 1.20e19.18) of its odds in
males, while, the odds of deuteranopia were lower in females
than males (0.52; 95% CI: 0.35e0.76).
By considering the 7e15 years age group as the reference
group, the odds of having CVD in 16e30 and 46e60 year age
groups were 0.52 (95% CI:0.37e0.73) and 1.41 (95% CI:
1.01e1.97), respectively. Also, the odds of having tritanopia in
16e30 year age group were lower than its odds in 7e15 year
age group (0.56; 95% CI:0.35e0.90). The odds of having
tritanopia in 46e60 year age group were higher than its odds
in 7e15 year age group (1.79; 95% CI:1.19e2.67).
Discussion
Congenital CVD is a common genetic disorder affecting
many patients worldwide. Its hereditary type is a recessive X-
linked disorder and is therefore more prevalent in men than
women.21 This disease causes a marked limitation and
disability in the patients, and usually affects a considerable
percentage of people depending on the population and its
characteristics.2e5,11,22e25
The results of our study showed a prevalence of 13.93% for
CVD in the study population, which is higher than other
countries (Table 3). The prevalence of CVD has been reported
to be 4.02% in Spain,26 7.33% in Turkey,4 10.3% in the
USA,27 and 2.56% in Italy.23
The findings of our study not only contradicted the notion
that “the incidence of CVD is lower in Asian countries as
compared with western countries”,4 but also showed a higher
prevalence in comparison with many Asian and Middle East
countries. For example, the prevalence of CVD has beenTable 1
The prevalence (95% confidence interval) of color vision deficiency (CVD) and it
Protanopia Deuteranopia Tritanopia
%(95%CI) %(95%CI) %(95%CI)
Total (n ¼ 2628) 0.8(0.45e1.15) 3.92(3.14e4.7) 6.96(5.84e8.08)
Sex Male (n ¼ 877) 0.23(0.06e0.91)a 5.7(4.18e7.23) 7.75(5.85e9.66)
Female (n ¼ 1751) 1.09(0.6e1.57) 3.03(2.21e3.84) 6.57(5.22e7.91)
Age 7e15 (n ¼ 582) 0.86(0.11e1.61) 5.5(3.72e7.27) 7.22(5.14e9.3)
16e30 (n ¼ 773) 0.26(0.06e1.04)a 1.94(0.98e2.9) 4.14(2.68e5.6)
31-45 (n ¼ 691) 0.72(0.09e1.36) 4.63(3.06e6.2) 5.64(3.82e7.46)
46e60 (n ¼ 453) 1.55(0.43e2.66)a 4.42(2.34e6.49) 12.14(9.06e15.22)
>60 (n ¼ 129) 1.55(0.39e6.15) 3.1(0.18e6.03) 11.63(5.88e17.38)
CI: Confidence interval.
a The 95%CI was calculated by binomial distribution.reported to be 5.28% in India,7 2.93% in Saudi Arabia,10 and
8.72% in Jordan.28 In addition to ethnic varieties, there may be
2 other reasons for this difference. The first reason could be
the tool used for the assessment of color vision. The Ishihara's
test was used in the studies conducted in Turkey,4 Spain,26 and
Italy23 while we used the Farnsworth D-15 test. The Farns-
worth D-15 is the second most commonly used test for the
detection of CVD after the Ishihara's test, and has a great
capability for detecting CVDs, especially blue-yellow defi-
ciency. Since the Ishihara's test can only detect red-green
deficiency and cannot detect blue-yellow deficiency, some
CVDs may be missed in studies that use the Ishihara's test, and
therefore, their prevalence is underestimated.29 The findings of
our study are in line with the results of a study1 that used the
Farnsworth D-15 test and reported a prevalence of 14.7%.
The second reason for the high prevalence of CVD in our
study could be cultural differences and the special conditions
of Mashhad, as the second largest religious city in Iran.
Although we did not investigate the effect of the consan-
guineous marriage on CVD, studies have shown increased
odds in countries with a high rate of consanguineous mar-
riages30 or where there are closed communities, like Muslim
communities10,11 and Ashkenazi Jews.31 It seems that Mash-
had, as one of the most religious cities of Iran, has a similar
condition leading to an increase in CVD. The differences
between our study and the studies conducted in other parts of
Iran confirm this hypothesis.19,20,32,33
Another finding of our study was the higher prevalence of
CVD inmen than women. The prevalence of color blindness was
15.85% in men and 12.96% in women. Although other studies
have also reported a higher prevalence of the disease in men
versus women,1,23e28,31,33 the prevalence of color blindness in
our female participants was higher than other studies. Although
this finding is in line with the findings of study,1 other previous
studies have not supported this finding.7,8,18e20,23e26,28,32,33
There may be two reasons for the difference. The first is the
test that was used to assess color vision. Most studies used the
Ishihara's test, but1 the ones whose results were similar to our
study used the Farnsworth D-15 test. The second reason which
is more important may be lack of differentiation between
congenital and acquired cases in this study, causing over-
estimation in the prevalence of CVD.s different types in the study population by sex and age groups.
Protanomalous Deuteranomalous Tritanomalous Color blindness
%(95%CI) %(95%CI) %(95%CI) %(95%CI)
0.34(0.09e0.59) 0.38(0.12e0.64) 2.21(1.55e2.86) 13.93(12.44e15.41)
0.46(0.01e0.9) 0.68(0.14e1.23) 1.82(0.83e2.82) 15.85(13.26e18.44)
0.29(0.1e0.81)a 0.23(0.07e0.76)a 2.4(1.66e3.14) 12.96(11.22e14.71)
0.17(0.03e1.18)a 1.03(0.08e1.98)a 2.41(1.15e3.66) 15.64(12.84e18.43)
0.65(0.08e1.21) 0.13(0.02e0.92) 1.68(0.76e2.6) 8.54(6.48e10.59)
0.14(0.02e1.03)a 0 2.32(1.19e3.44) 12.88(10.34e15.42)
0.44(0.06e3.12)a 0.44(0.11e1.78)a 2.21(0.77e3.65) 20.53(16.31e24.75)
0 0.78(0.11e5.45)a 3.88(0.66e7.09) 20.93(13.63e28.23)
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83H. Hashemi et al. / Journal of Current Ophthalmology 31 (2019) 80e85The type of CVD depends on whether it is congenital or
acquired. Red-green deficiency is more common in patients
with congenital CVD,4 and yellow-blue deficiency is more
common in patients with acquired CVD.1
In our study, tritanopia was the most common type of CVD
with a prevalence of 6.96%, followed by deuteranopia, and
tritanomalous with a prevalence of 3.92%, and 2.21%,
respectively. This order was also true for male and female
participants. It seems that the higher prevalence of tritanopia
in our study is due to the use of the Farnsworth D-15 test that
can detect CVDs, especially blue-yellow deficiency.29 Our
results are in agreement with the findings of other studies1,14,34
that used this test, and this can be a support for our
justification.
The association between age and CVD was another finding
of our study. The odds of having CVD were lower in 16e30
and higher in 46e60 year age groups compared to 7e15 year
age group. It seems that the prevalence of CVD decreases until
midlife and sharply increases thereafter. This pattern also
holds for tritanopia. Individuals in older ages have a higher
risk for developing ocular pathologies like cataract,35 glau-
coma,36,37 retinal disorders,38 systemic diseases (e.g., dia-
betes),39 and more exposure to environmental factors which
have influence on acquired color deficiency.40e42 All of these
increase the risk of acquired CVD. This issue can explain the
observed associations in this study.
A strong point of our study is its large sample size as we
evaluated about 2628 people. Therefore, our results are valid
and have a high generalizability. Moreover, our sampling
made it possible to include all age groups into the study to
assess the relationship between age and the prevalence of
CVD, which has been evaluated in a few studies.
Another strong point of this study is the use of the Farns-
worth D-15 test instead of Ishihara's test, which enables us to
explain our different findings, as well. In contrast to Ishihara's
test that can only detect red-green deficiency, the Farnsworth
D-15 can detect blue-yellow deficiency as well. This is espe-
cially important in the statistics of acquired CVD because
most acquired cases have blue-yellow deficiency which may
be missed on the Ishihara's test.
A limitation of this study is the lack of differentiation be-
tween acquired and congenital CVD, which may itself explain
some differences with the results of previous studies. Some
studies only reported the prevalence of congenital CVD and
reported the prevalence of acquired and congenital CVD
separately, which could lead to different results.
Another limitation of this report is that, we could not
evaluate the association between some age-related ocular pa-
thologies like cataract and glaucoma with CVD. The associ-
ation between CVD and age may be due to the association
between CVD and age-related ocular pathologies. Unfortu-
nately, we were not able to explore such associations with the
available data. Also, there may be other potential confounders
that its effects have not been controlled in this study.
However, this study is very valuable due to its large sample
size and population-based design, and its results can be used in
health system policies.
Table 3
The prevalence of color vision deficiency (CVD) in different countries and other cities in Iran.
Location
In the World
Age Sample
size
Type of color blindness Screen test Prevalence
Male% Female% Total%
Saudi Arabia, 199610 11e18 410 congenital red-green color vision defects Ishihara test e e 2.93
Turkey, 20024 20e26 941 Congenital Color Blindness Ishihara test e e 7.33
India, 20127 e 2674 Congenital Color Blindness Ishihara test 8.73 1.69 5.28
India, 201321 6e15 1028 Color vision deficiency Ishihara test 11.36 3.03 e
Philippines, 20106 12e16 1258 Color vision deficiency Ishihara and
Farnsworth D-15 test
e e 5.17
Nepal, 201243 19e26 215 Color vision deficiency Ishihara test e e 5.58
Nepal, 201216 Medical student 120 congenital color vision defects Ishihara test e e 5.83
Korea, 198924 Middle school 9438 congenital color vision defects Hardy-Rand-Rittler 5.9 0.44 3.15
Nepal, 200625 10e19 964 Color vision deficiency Ishihara test 3.8 0 1.86
Italy, 199223 e 3133 red-green color vision defects Ichikawa plates 2.56 0.1 1.05
Jordan, 200128 university students 1418 congenital red/green color blindness Ishihara test 8.72 0.33 1.62
America, 198527 All ages 2499 Color vision deficiency e 20.4 1.8 10.8
Spain, 199026 student 392 red/green color blindness Ishihara test 4.02 0.46 2.04
In The Iran
Tehran, Iran, 20138 7e12 2160 Color vision deficiency Yang vision tester 3.5 1 2.2
Shahroud, Iran, 20131 40e64 5102 Color vision deficiency Farnsworth D-15 16.6 13.3 14.7
Tehran, Iran, 199618 12e14 2058 Color vision deficiency Ishihara test 4.51 0.19 4.71
Zahedan, Iran, 201233 primary school 1000 red/green color blindness Ishihara test 1.6 0.2 0.9
Mashhad, Iran 2009
(current study)
All ages 2628 Color vision deficiency Farnsworth D-15 15.85 12.96 13.93
84 H. Hashemi et al. / Journal of Current Ophthalmology 31 (2019) 80e85In conclusion, the prevalence of CVD was high in Mash-
had, especially in males and people over 46 years of age.
Planning for involvement of ocular disease control programs
in health care systems can be helpful in the reduction of CVD
and improving the quality of life in affected patients.
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